Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm

European Urology
F BeckerM Stöckle

Abstract

Elective nephron-sparing surgery (NSS) for renal cell carcinoma (RCC) < 4 cm has been accepted as alternative to radical nephrectomy (RN). However, NSS for tumours > 4 cm is controversial. We present our experiences and long-term oncologic outcome of RCC > 4 cm treated with NSS in a retrospective single-institutional analysis of 69 patients. Between 1975 and 2004, elective NSS was performed in 368 patients at our institution, including 69 patients with sporadic, nonmetastatic RCC > 4 cm. Overall and cancer-specific survivals were estimated using the Kaplan-Meier method. Complications were seen in nine patients (13.0%). After a mean follow-up of 6.2 yr (median, 5.8 yr) seven patients (10.1%) had died, none of them of tumour-related causes. Tumour recurrence was detected in four patients (5.8%). The 5-yr overall survival probability was 94.9%. The 10-yr and 15-yr overall survival rates were both 86.7%. Cancer-specific survival was 100% after 5, 10, and 15 yr. Selected patients with localized RCC even > 4 cm can be treated with elective NSS providing optimal long-term outcome. The surgeon's decision for organ-preserving surgery should depend on tumour localisation and technical feasibility rather than on tumour size.

References

Aug 9, 2002·Annals of Surgical Oncology·Paul RussoVictor Reuter
May 6, 2004·The Journal of Urology·Jean-Jacques PatardArie S Belldegrun
Oct 12, 2004·European Urology·Vincenzo FicarraWalter Artibani
Sep 6, 2005·Urology·Gary M Israel, Morton A Bosniak

❮ Previous
Next ❯

Citations

Feb 6, 2008·Der Urologe. Ausg. A·F BeckerM Stöckle
Sep 1, 2011·Der Urologe. Ausg. A·A Heidenreich
Mar 22, 2012·Der Urologe. Ausg. A·H LoertzerA Strauß
Mar 6, 2010·World Journal of Urology·Francesco PorpigliaGunter Janetschek
Dec 10, 2009·Wiener medizinische Wochenschrift·Richard Zigeuner, Karl Pummer
Mar 27, 2013·International Urology and Nephrology·Benjamin WoodsonBenjamin R Lee
Dec 7, 2006·Nature Clinical Practice. Urology·Frank BeckerMichael Stöckle
Jan 11, 2008·Nature Clinical Practice. Urology·Matthew F WszolekJohn A Libertino
May 31, 2012·Advances in Urology·Eugene J Pietzak, Thomas J Guzzo
Aug 24, 2011·Annals of Surgical Oncology·Andrea MinerviniMarco Carini
Dec 4, 2009·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Monish Aron, Burak Turna
Apr 8, 2011·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Rodney H BreauIlias Cagiannos
Jun 15, 2013·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Fahad A Alyami, Ricardo A Rendon
Jan 15, 2014·Nature Reviews. Nephrology·Lin LiKamyar Kalantar-Zadeh
Jun 30, 2009·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Y RouachA Mejean
Jun 3, 2014·BMC Cancer·Frederik C RoosUNKNOWN German Renal Cell Cancer Network
Nov 28, 2012·Der Urologe. Ausg. A·T J SchnoellerA J Schrader
Sep 24, 2014·AJR. American Journal of Roentgenology·Priya R BhosaleDeepak G Bedi
Oct 14, 2011·World Journal of Surgical Oncology·Thomas J SchnoellerAndres J Schrader
Aug 31, 2013·World Journal of Surgical Oncology·Jun QiYu Wu
Dec 14, 2011·European Urology·Preston C SprenkleJonathan A Coleman
Sep 29, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A LecouteuxG Karam
Jul 6, 2011·European Urology·Hein Van PoppelGang Zhu
Aug 7, 2009·European Urology·Frank BeckerMichael Stöckle
Dec 22, 2015·Actas urologicas españolas·A VilasecaA Alcaraz
Jan 27, 2009·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·M PeycelonM Rouprêt
Sep 9, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L ZiniP Karakiewicz
Jul 22, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A MinerviniM Carini
Sep 2, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·M CrépelJ-J Patard
May 27, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·G VerhoestJ-J Patard
Jan 29, 2008·European Urology·Francesco PorpigliaRoberto Mario Scarpa
Dec 7, 2007·European Urology·Karim BensalahJean-Jacques Patard
Jan 24, 2007·European Urology·Jean-Jacques PatardArie S Belldegrun
Jan 19, 2007·European Urology·Andreas SkolarikosJean de la Rosette
Apr 20, 2007·BJU International·Brian R Lane, Andrew C Novick
Apr 4, 2007·Transplant International : Official Journal of the European Society for Organ Transplantation·Claudia E FalkensammerJustin H Nguyen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.